NYSE:BLCOMedical Equipment
Bausch + Lomb (BLCO) Could Be 57% Undervalued As Board Refresh Draws Attention
Bausch + Lomb (BLCO) drew fresh attention after appointing four new directors on August 5, 2026, replacing four outgoing board members. Investors are now weighing how this refreshed oversight might influence the company.
See our latest analysis for Bausch + Lomb.
Bausch + Lomb’s share price has shown building momentum, with a 7 day share price return of 3.85% and a 30 day share price return of 6.39%. The 1 year total shareholder return sits at 20.60%, compared with a 3 year total shareholder...